• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Laurus Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540222
INE947Q01028
97.2840104
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LAURUSLABS
104.02
77048.33
EPS(TTM)
Face Value()
Div & Yield %
13.72
2
0.08
 

Dilip Buildcon consolidated net profit declines 63.68% in the March 2026 quarter
May 14,2026
Net profit of Dilip Buildcon declined 63.68% to Rs 62.05 crore in the quarter ended March 2026 as against Rs 170.83 crore during the previous quarter ended March 2025. Sales declined 25.72% to Rs 2299.81 crore in the quarter ended March 2026 as against Rs 3096.10 crore during the previous quarter ended March 2025.

For the full year,net profit rose 103.23% to Rs 1302.37 crore in the year ended March 2026 as against Rs 640.83 crore during the previous year ended March 2025. Sales declined 20.61% to Rs 8983.93 crore in the year ended March 2026 as against Rs 11316.72 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2299.813096.10 -26 8983.9311316.72 -21
OPM %17.0621.35 -19.6519.00 -
PBDT217.19401.28 -46 878.411038.40 -15
PBT149.47314.25 -52 580.73692.22 -16
NP62.05170.83 -64 1302.37640.83 103